We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Tag: Gynecologic Oncology
MedXY News
EnglishTag

Gynecologic Oncology

Ask MedXY AI
type 2 diabetesclinical trialheart failureimmunotherapyobesitycardiovascular riskatrial fibrillationbiomarkerscritical careclinical trialsHypertensionartificial intelligenceCardiologyoncologypublic healthtype 1 diabetesdiabetesMortalityAlzheimer's diseasecardiovascular diseasebreast cancerepidemiology

Latest news

Tag

No Time to Waste: Addressing Diagnostic Delays in Vulvar Squamous Cell Carcinoma
newsdiagnostic delayGynecologic Oncology

No Time to Waste: Addressing Diagnostic Delays in Vulvar Squamous Cell Carcinoma

By MedXY|Aug 25, 2026

This article reviews a study identifying key factors contributing to delays in diagnosing vulvar squamous cell carcinoma, emphasizing provider and system-level influences and the need for timely biopsy and specialist referrals.

Early-phase vs. late-phase clinical trials in gynecologic oncology: Trends in trial completion, reporting, and enrollment of racial and ethnic minority groups
Clinical UpdatesGynecologic Oncology
trial reporting

Early-phase vs. late-phase clinical trials in gynecologic oncology: Trends in trial completion, reporting, and enrollment of racial and ethnic minority groups

By MedXY|Aug 22, 2026

This review contrasts early- and late-phase gynecologic oncology trials, underscoring disparities in trial completion, publication, and racial/ethnic minority enrollment, highlighting the need to improve inclusivity and reporting.

Enhancing Patient Engagement in Gynecologic Oncology Clinical Trials Through a Pilot Patient Ambassador Program
newspatient ambassadorpeer education

Enhancing Patient Engagement in Gynecologic Oncology Clinical Trials Through a Pilot Patient Ambassador Program

By MedXY|Aug 21, 2026

A pilot program using former gynecologic oncology trial participants as patient ambassadors improved confidence and perceptions about clinical trials among trial-naïve patients, highlighting a feasible peer-education approach.

Enhanced Gynecologic Oncology Decision Support: Impact of Guideline-Anchored Retrieval-Augmented Generation Versus Baseline and Literature-Based AI Models
newsGynecologic Oncologylarge language models

Enhanced Gynecologic Oncology Decision Support: Impact of Guideline-Anchored Retrieval-Augmented Generation Versus Baseline and Literature-Based AI Models

By MedXY|Aug 18, 2026

A study benchmarking large language models in gynecologic oncology demonstrates that guideline-anchored retrieval-augmented generation (RAG) configurations outperform baseline and literature-only AI systems in clinical decision support, hig

Unraveling Failure to Rescue in Major Gynecologic Cancer Surgery: Insights from a NSQIP Analysis
newsGynecologic Oncology术后并发症

Unraveling Failure to Rescue in Major Gynecologic Cancer Surgery: Insights from a NSQIP Analysis

By MedXY|Aug 18, 2026

This study identifies key patient-level factors associated with failure to rescue after major gynecologic oncology surgery, emphasizing complication severity and physiological reserve over procedure complexity.

Adding HE4 to the IOTA ADNEX Model for Differentiating Adnexal Masses: A Danish Prospective Multicenter Study
newsHE4ovarian cancer risk

Adding HE4 to the IOTA ADNEX Model for Differentiating Adnexal Masses: A Danish Prospective Multicenter Study

By MedXY|Aug 18, 2026

A Danish multicenter study found that adding HE4 to the IOTA ADNEX model offered only limited, threshold-dependent benefit for assessing adnexal masses, with no meaningful improvement in non-tertiary centers.

Community-Centered Education Improves Clinical Trial Knowledge and Self-Efficacy Among Minoritized Women
newsclinical trialscommunity engagement

Community-Centered Education Improves Clinical Trial Knowledge and Self-Efficacy Among Minoritized Women

By MedXY|Apr 26, 2026

A culturally tailored educational intervention significantly improved clinical trial knowledge and self-efficacy among African American and Hispanic women, highlighting the potential of community partnerships to address disparities in gynec

Prophylactic Antibiotics Did Not Significantly Reduce Infection After Vulvar Surgery, Cohort Study Finds
newsGynecologic Oncologypostoperative infection

Prophylactic Antibiotics Did Not Significantly Reduce Infection After Vulvar Surgery, Cohort Study Finds

By MedXY|Apr 20, 2026

In a prospective cohort of 172 vulvar surgery patients, prophylactic antibiotics were not associated with fewer postoperative infections or complications, supporting the need for a randomized trial.

Stool Biospecimen Collection in Gynecologic Oncology: New Study Demonstrates Feasibility and Identifies Provider Engagement as Key Driver
newsbiospecimen collectionfeasibility study

Stool Biospecimen Collection in Gynecologic Oncology: New Study Demonstrates Feasibility and Identifies Provider Engagement as Key Driver

By MedXY|Apr 2, 2026

A prospective study evaluating at-home stool collection for gut microbiome research in gynecologic oncology demonstrates implementation feasibility with 61% patient enrollment. Provider engagement emerged as the strongest predictor of parti

Beyond the Pink Ribbon: Analyzing the Funding Disparity in Gynecologic vs. Breast Cancer Survivorship Research
Medical NewsGynecologic Oncologyhealth equity

Beyond the Pink Ribbon: Analyzing the Funding Disparity in Gynecologic vs. Breast Cancer Survivorship Research

By MedXY|Mar 22, 2026

This evidence-based review examines the significant disparity in NIH funding for cancer survivorship, revealing that gynecologic cancer research receives nearly five times less funding per survivor than breast cancer research.

Peritoneal Cancer Risk After Risk-Reducing Salpingo-Oophorectomy: The Impact of BRCA Mutational Status and STIC Lesions
newsBRCA1BRCA2

Peritoneal Cancer Risk After Risk-Reducing Salpingo-Oophorectomy: The Impact of BRCA Mutational Status and STIC Lesions

By MedXY|Mar 15, 2026

This study of 1,351 high-risk women demonstrates that while risk-reducing salpingo-oophorectomy (RRSO) is effective, the presence of serous tubal intraepithelial carcinoma (STIC) at the time of surgery significantly increases the 5-year ris

Ribociclib Plus Letrozole Shows Potent Activity in Recurrent Low-Grade Serous Ovarian Carcinoma: Results from GOG 3026
newsCDK4/6 inhibitorsGynecologic Oncology

Ribociclib Plus Letrozole Shows Potent Activity in Recurrent Low-Grade Serous Ovarian Carcinoma: Results from GOG 3026

By MedXY|Jan 19, 2026

The GOG 3026 phase II trial demonstrates that the combination of ribociclib and letrozole provides significant clinical benefit and durable responses in patients with recurrent low-grade serous carcinoma, representing a major step forward f

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities